Member area login
You don't have or don't remember the password!
Click Here
Maria Stella Graziani

Deputy Director
Martina Zaninotto

Associate Editors
Ferruccio Ceriotti
Davide Giavarina
Bruna Lo Sasso
Giampaolo Merlini
Martina Montagnana
Andrea Mosca
Paola Pezzati
Rossella Tomaiuolo
Matteo Vidali

EIC Assistant
Francesco Busardò

International Advisory Board Khosrow Adeli Canada
Sergio Bernardini Italy
Marcello Ciaccio Italy
Eleftherios Diamandis Canada
Philippe Gillery France
Kjell Grankvist Sweden
Hans Jacobs The Netherlands
Eric Kilpatrick UK
Magdalena Krintus Poland
Giuseppe Lippi Italy
Mario Plebani Italy
Sverre Sandberg Norway
Ana-Maria Simundic Croatia
Tommaso Trenti Italy
Cas Weykamp The Netherlands
Maria Willrich USA
Paul Yip Canada

Biomedia srl
Via L. Temolo 4, 20126 Milano

Responsible Editor
Giuseppe Agosta

Editorial Secretary
Chiara Riva
Biomedia srl
Via L. Temolo 4, 20126 Milano
Tel. 0245498282


ISSN print: 0393 – 0564
ISSN digital: 0392- 7091

BC: Articoli scritti da C.M.G. De Luca

Microbiota intestinale e nasale nella malattia di Parkinson
Gut and nasal microbiota in Parkinson’s disease.
<p><span style="color:#221E1F; font-family:calibri,sans-serif; font-size:9.0pt">Parkinson&rsquo;s disease (PD) is a neurodegenerative condition characterized by a series of symptoms that anticipate overt disease. In particular, rapid eye movement (REM) sleep behavior disorders, intestinal problems and olfactory impairment are the most frequent prodromal signs of the disease. Compelling evidence suggests that, among other factors, the microbiota might play an important role in the onset and progression of PD. While several findings confirmed that there might be an important link between intestinal microbiota alterations and PD onset, little is known about the potential contribution of the nasal microbiota. Here, we will describe the latest findings on this topic by considering that more than 80% of patients with PD develop remarkable olfactory deficits in their prodromal disease stage. Therefore, the nasal microbiota might contribute to PD, eventually boosting the intestinal microbiota in promoting disease onset.</span></p>
Biochimica Clinica ; 46(3) 201-208
Rassegne - Reviews